DE69431476D1 - Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung - Google Patents

Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung

Info

Publication number
DE69431476D1
DE69431476D1 DE69431476T DE69431476T DE69431476D1 DE 69431476 D1 DE69431476 D1 DE 69431476D1 DE 69431476 T DE69431476 T DE 69431476T DE 69431476 T DE69431476 T DE 69431476T DE 69431476 D1 DE69431476 D1 DE 69431476D1
Authority
DE
Germany
Prior art keywords
taxotere
taxol
cyclodextrines
production
including complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69431476T
Other languages
English (en)
Other versions
DE69431476T2 (de
Inventor
Lajos Szente
Jetazsef Szejili
Andrasne Vikmon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of DE69431476D1 publication Critical patent/DE69431476D1/de
Application granted granted Critical
Publication of DE69431476T2 publication Critical patent/DE69431476T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69431476T 1993-05-12 1994-05-09 Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung Expired - Lifetime DE69431476T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9301373A HU213200B (en) 1993-05-12 1993-05-12 The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
PCT/HU1994/000012 WO1994026728A1 (en) 1993-05-12 1994-05-09 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use

Publications (2)

Publication Number Publication Date
DE69431476D1 true DE69431476D1 (de) 2002-11-07
DE69431476T2 DE69431476T2 (de) 2003-06-18

Family

ID=10983581

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69431476T Expired - Lifetime DE69431476T2 (de) 1993-05-12 1994-05-09 Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung

Country Status (23)

Country Link
US (1) US6284746B1 (de)
EP (1) EP0698018B1 (de)
JP (1) JP3693341B2 (de)
CN (1) CN1123030A (de)
AT (1) ATE225340T1 (de)
AU (1) AU693101B2 (de)
BG (1) BG100207A (de)
BR (1) BR9406292A (de)
CA (1) CA2162716C (de)
CZ (1) CZ291495A3 (de)
DE (1) DE69431476T2 (de)
DK (1) DK0698018T3 (de)
ES (1) ES2184764T3 (de)
FI (1) FI955424A (de)
HU (1) HU213200B (de)
IL (1) IL109613A (de)
NO (1) NO954545L (de)
OA (1) OA10323A (de)
PL (1) PL311561A1 (de)
PT (1) PT698018E (de)
SK (1) SK140595A3 (de)
WO (1) WO1994026728A1 (de)
YU (1) YU26894A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
CN100396276C (zh) * 1998-02-05 2008-06-25 诺瓦提斯公司 依普西龙组合物
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
TWI321054B (en) * 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
GB0127677D0 (en) * 2001-11-19 2002-01-09 Vianex S A Inclusion complex
US20040106199A1 (en) * 2002-12-02 2004-06-03 Eliseev Alexey V. Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media
CN100486645C (zh) * 2006-09-12 2009-05-13 南京师范大学 含有环糊精紫杉醇包合物的药物组合物及其制备方法
CN100411688C (zh) * 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
CN101278929B (zh) * 2007-04-02 2011-05-18 王效山 含有藤黄酸类化合物的药物及藤黄酸类化合物的包合物的制备方法
ES2310122B1 (es) * 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
ITMI20071321A1 (it) * 2007-07-04 2009-01-05 Sea Marconi Technologies Di Va Nanospugne a base di ciclodestrine come veicolo per farmaci antitumorali
CL2007003876A1 (es) * 2007-12-28 2008-03-07 Univ De Concepcion Y Lab Andro Complejo de inclusion que esta formado por disulfiram y ciclodextrina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de la dependencia de alcohol y cocaina.
US9492417B2 (en) 2008-08-21 2016-11-15 The Johns Hopkins University Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
EP3094313A4 (de) * 2014-01-14 2017-07-12 The Johns Hopkins University Liposomzusammensetzungen zur einkapselung modifizierter cyclodextrinkomplexe und verwendungen davon
CN103920163B (zh) * 2014-03-14 2016-09-14 南京大学 一种紫杉醇复合物、制备方法及其应用
WO2017079563A1 (en) 2015-11-06 2017-05-11 The Johns Hopkins University Methods of treating liver fibrosis by administering 3-bromopyruvate
GB201715008D0 (en) * 2017-09-18 2017-11-01 Inst De Medicina Molecular Faculdade De Medicina Univ De Lisboa TRPV2 Antagonists
EP3827822A4 (de) 2018-07-25 2022-05-04 Bika Biotechnology (Guangzhou) Co., Ltd. Docetaxelzusammensetzung zur injektion und herstellungsverfahren dafür

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
JPS62120324A (ja) * 1985-11-20 1987-06-01 Nippon Junyaku Kk 有機物質の水溶化方法
JP2651567B2 (ja) * 1986-03-20 1997-09-10 花王株式会社 メチル化β−シクロデキストリン
IE62095B1 (en) * 1988-03-29 1994-12-14 Univ Florida Pharmaceutical formulations for parenteral use
JP2929108B2 (ja) * 1988-10-28 1999-08-03 株式会社資生堂 化粧料および粉末化粧料
IT1227626B (it) 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
JPH02200671A (ja) * 1989-01-30 1990-08-08 Agency Of Ind Science & Technol インドールを抽出分離する方法およびインドール包接分離用薬剤
JPH035438A (ja) * 1989-05-31 1991-01-11 Kaken Pharmaceut Co Ltd フルルビプロフェン包接化合物およびこの包接化合物を用いる消炎鎮痛剤
GB8920135D0 (en) * 1989-09-06 1989-10-18 Erba Carlo Spa Use of dehydrated cyclodextrins for improving drug dissolution
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
HU211648A9 (en) 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
US5241059A (en) * 1990-05-21 1993-08-31 Toppan Printing Co., Ltd. Cyclodextrin derivatives
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
JPH0753396A (ja) * 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法および用途
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor

Also Published As

Publication number Publication date
BR9406292A (pt) 1995-12-26
FI955424A0 (fi) 1995-11-10
IL109613A (en) 1997-09-30
CZ291495A3 (en) 1996-04-17
PT698018E (pt) 2003-02-28
HUT68589A (en) 1995-06-28
US6284746B1 (en) 2001-09-04
SK140595A3 (en) 1996-10-02
AU693101B2 (en) 1998-06-25
IL109613A0 (en) 1994-08-26
NO954545D0 (no) 1995-11-10
WO1994026728A1 (en) 1994-11-24
ATE225340T1 (de) 2002-10-15
DK0698018T3 (da) 2003-02-10
AU7008194A (en) 1994-12-12
OA10323A (en) 1997-10-07
FI955424A (fi) 1995-11-10
PL311561A1 (en) 1996-02-19
YU26894A (sh) 1997-05-28
HU213200B (en) 1997-03-28
CN1123030A (zh) 1996-05-22
EP0698018A1 (de) 1996-02-28
NO954545L (no) 1995-11-10
JPH08510232A (ja) 1996-10-29
JP3693341B2 (ja) 2005-09-07
EP0698018B1 (de) 2002-10-02
ES2184764T3 (es) 2003-04-16
CA2162716C (en) 2005-03-08
HU9301373D0 (en) 1993-09-28
CA2162716A1 (en) 1994-11-24
DE69431476T2 (de) 2003-06-18
BG100207A (bg) 1996-05-31

Similar Documents

Publication Publication Date Title
DE69431476D1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
BR9307401A (pt) Composi-{es de extrato da casca de carvalho composi-{es sint-ticas relacionadas e m-todo de usar as mesmas
DE69018601D1 (de) Konzentrate von aktiven Verbindungen und Kombinationen von aktiven Verbindungen, ihre Verfahren zur Herstellung und Arzneimittel, die die Konzentrate oder die Kombinationen enthalten.
DE59309733D1 (de) Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
ATE11547T1 (de) Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit.
ATE25238T1 (de) Pharmazeutische zusammensetzungen zur behandlung von entzuendungen oder arthritis.
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
ATE42466T1 (de) Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis.
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE24282T1 (de) Verfahren zur herstellung von pharmazeutischen und kosmetischen dispersionen.
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
ATE229803T1 (de) Verwendung eines flavonoid enthaltenden extraktes der planze euphorbia prostrata zur herstellung eines medikamentes zur behandlung von anoraktalen oder kolonbeschwerden
DE69610045T2 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
DE69408664D1 (de) Zusammensetzungen zur behandlung von geernteter pflanzenmaterial
ATE127118T1 (de) 2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.
UA27023C2 (uk) Спосіб профілактики та лікуваhhя серцево-судиhhих захворюваhь
DE68907596D1 (de) Herstellung von 2-phenyl-propan-1,3-diol und dessen dicarbamat.
HUP0001505A1 (hu) Aktivált, K-vitamintól függő vérfaktor és eljárás előállítására

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HEXAL AG, 83607 HOLZKIRCHEN, DE